This one is particularly disappointing due to more than just the chart. The company has not delivered on its promises. It is a common sight in pharma/biotech startups.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red....
